Cargando…
Current management of cervical cancer in Poland—Analysis of the questionnaire trial for the years 2002-2014 in relation to ASCO 2016 recommendations
OBJECTIVES: To assess the survival of patients with cervical cancer (CC). Since the recommendations concerning cervical cancer management adopted by Polish medical societies do not differ significantly from the ESGO or non-European guidelines, and the fact that evaluation of the system for CC treatm...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354992/ https://www.ncbi.nlm.nih.gov/pubmed/30703105 http://dx.doi.org/10.1371/journal.pone.0209901 |
_version_ | 1783391284485947392 |
---|---|
author | Basta, Tomasz Knapp, Paweł Blecharz, Paweł Bodnar, Lubomir Gawron, Iwona Babczyk, Dorota Piróg, Magdalena Kluz, Tomasz Markowska, Anna Horbaczewska, Anna Jach, Robert |
author_facet | Basta, Tomasz Knapp, Paweł Blecharz, Paweł Bodnar, Lubomir Gawron, Iwona Babczyk, Dorota Piróg, Magdalena Kluz, Tomasz Markowska, Anna Horbaczewska, Anna Jach, Robert |
author_sort | Basta, Tomasz |
collection | PubMed |
description | OBJECTIVES: To assess the survival of patients with cervical cancer (CC). Since the recommendations concerning cervical cancer management adopted by Polish medical societies do not differ significantly from the ESGO or non-European guidelines, and the fact that evaluation of the system for CC treatment in Poland, as well as the mortality rate of Polish women with CC, which is 70% higher than the average for European Union (EU) countries, justifies the hypothesis that treatment of CC in Poland deviates from the Polish and international recommendations. This article puts forward the current management of cervical cancer in Poland and discusses it in the context of ASCO guidelines. MATERIAL AND METHODS: A survey retrospective multicenter analysis of the medical records of 1247 patients with cervical cancer who underwent treatment for disease and who had completed at least two years of follow-up. RESULTS: Although concurrent radiotherapy and chemotherapy is a standard treatment of FIGO IB to IVA cervical cancer patients in enhanced- and maximum-resources settings, in our analysis, we found that the percentage of women subjected to chemotherapy was lower than in countries where total survival rates were lower. CONCLUSION: Within the IA to II A cervical cancer patients studied group, the methods of treatment remained in line with ASCO guidelines for countries with the highest standard of care. Although concurrent radiotherapy and chemotherapy is a standard treatment of FIGO IB to IVA cervical cancer patients in enhanced- and maximum-resources settings, in our analysis, we found that the percentage of women subjected to chemotherapy was lower than in countries where total survival rates were lower. Our findings, together with the inconsistencies within the cervical cancer screening program, may be one of the explanations of poorer survival rate of women with cervical cancer in Poland. |
format | Online Article Text |
id | pubmed-6354992 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-63549922019-02-15 Current management of cervical cancer in Poland—Analysis of the questionnaire trial for the years 2002-2014 in relation to ASCO 2016 recommendations Basta, Tomasz Knapp, Paweł Blecharz, Paweł Bodnar, Lubomir Gawron, Iwona Babczyk, Dorota Piróg, Magdalena Kluz, Tomasz Markowska, Anna Horbaczewska, Anna Jach, Robert PLoS One Research Article OBJECTIVES: To assess the survival of patients with cervical cancer (CC). Since the recommendations concerning cervical cancer management adopted by Polish medical societies do not differ significantly from the ESGO or non-European guidelines, and the fact that evaluation of the system for CC treatment in Poland, as well as the mortality rate of Polish women with CC, which is 70% higher than the average for European Union (EU) countries, justifies the hypothesis that treatment of CC in Poland deviates from the Polish and international recommendations. This article puts forward the current management of cervical cancer in Poland and discusses it in the context of ASCO guidelines. MATERIAL AND METHODS: A survey retrospective multicenter analysis of the medical records of 1247 patients with cervical cancer who underwent treatment for disease and who had completed at least two years of follow-up. RESULTS: Although concurrent radiotherapy and chemotherapy is a standard treatment of FIGO IB to IVA cervical cancer patients in enhanced- and maximum-resources settings, in our analysis, we found that the percentage of women subjected to chemotherapy was lower than in countries where total survival rates were lower. CONCLUSION: Within the IA to II A cervical cancer patients studied group, the methods of treatment remained in line with ASCO guidelines for countries with the highest standard of care. Although concurrent radiotherapy and chemotherapy is a standard treatment of FIGO IB to IVA cervical cancer patients in enhanced- and maximum-resources settings, in our analysis, we found that the percentage of women subjected to chemotherapy was lower than in countries where total survival rates were lower. Our findings, together with the inconsistencies within the cervical cancer screening program, may be one of the explanations of poorer survival rate of women with cervical cancer in Poland. Public Library of Science 2019-01-31 /pmc/articles/PMC6354992/ /pubmed/30703105 http://dx.doi.org/10.1371/journal.pone.0209901 Text en © 2019 Basta et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Basta, Tomasz Knapp, Paweł Blecharz, Paweł Bodnar, Lubomir Gawron, Iwona Babczyk, Dorota Piróg, Magdalena Kluz, Tomasz Markowska, Anna Horbaczewska, Anna Jach, Robert Current management of cervical cancer in Poland—Analysis of the questionnaire trial for the years 2002-2014 in relation to ASCO 2016 recommendations |
title | Current management of cervical cancer in Poland—Analysis of the questionnaire trial for the years 2002-2014 in relation to ASCO 2016 recommendations |
title_full | Current management of cervical cancer in Poland—Analysis of the questionnaire trial for the years 2002-2014 in relation to ASCO 2016 recommendations |
title_fullStr | Current management of cervical cancer in Poland—Analysis of the questionnaire trial for the years 2002-2014 in relation to ASCO 2016 recommendations |
title_full_unstemmed | Current management of cervical cancer in Poland—Analysis of the questionnaire trial for the years 2002-2014 in relation to ASCO 2016 recommendations |
title_short | Current management of cervical cancer in Poland—Analysis of the questionnaire trial for the years 2002-2014 in relation to ASCO 2016 recommendations |
title_sort | current management of cervical cancer in poland—analysis of the questionnaire trial for the years 2002-2014 in relation to asco 2016 recommendations |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354992/ https://www.ncbi.nlm.nih.gov/pubmed/30703105 http://dx.doi.org/10.1371/journal.pone.0209901 |
work_keys_str_mv | AT bastatomasz currentmanagementofcervicalcancerinpolandanalysisofthequestionnairetrialfortheyears20022014inrelationtoasco2016recommendations AT knapppaweł currentmanagementofcervicalcancerinpolandanalysisofthequestionnairetrialfortheyears20022014inrelationtoasco2016recommendations AT blecharzpaweł currentmanagementofcervicalcancerinpolandanalysisofthequestionnairetrialfortheyears20022014inrelationtoasco2016recommendations AT bodnarlubomir currentmanagementofcervicalcancerinpolandanalysisofthequestionnairetrialfortheyears20022014inrelationtoasco2016recommendations AT gawroniwona currentmanagementofcervicalcancerinpolandanalysisofthequestionnairetrialfortheyears20022014inrelationtoasco2016recommendations AT babczykdorota currentmanagementofcervicalcancerinpolandanalysisofthequestionnairetrialfortheyears20022014inrelationtoasco2016recommendations AT pirogmagdalena currentmanagementofcervicalcancerinpolandanalysisofthequestionnairetrialfortheyears20022014inrelationtoasco2016recommendations AT kluztomasz currentmanagementofcervicalcancerinpolandanalysisofthequestionnairetrialfortheyears20022014inrelationtoasco2016recommendations AT markowskaanna currentmanagementofcervicalcancerinpolandanalysisofthequestionnairetrialfortheyears20022014inrelationtoasco2016recommendations AT horbaczewskaanna currentmanagementofcervicalcancerinpolandanalysisofthequestionnairetrialfortheyears20022014inrelationtoasco2016recommendations AT jachrobert currentmanagementofcervicalcancerinpolandanalysisofthequestionnairetrialfortheyears20022014inrelationtoasco2016recommendations |